BackOnconova Therapeutics- Warrants (01/08/2021) Overview

Onconova Therapeutics- Warrants (01/08/2021) Net Income

Profitability analysis for ONTXW.

Quarterly Net Income

-$7.11M

As of Mar 2026

Annual Net Income (TTM)

$9.15B
26444.41% YoY

Trailing 12 months ending Mar 2026

Average Net Income (Comparison Companies)

Loading

Net Income History

Loading

Net Income Comparison

Loading

Annual Net Income Growth Rate (%)

Loading...

Annual Net Income Growth (Absolute)

Loading...